While SGLT2 inhibition has a more isolated mechanism involving renal glucose control, the broad anti-inflammatory properties of CBD could offer an improved overall therapeutic effect when used as a combination therapy for T2DM. Here, SLC5A2 is linked to type 2 diabetes mellitus.